Authors/Disclosures
|
Maria C. Soladana, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
John S. Duncan, MD
(National Hospital for Nervous)
|
No disclosure on file |
|
Mark Richardson, MD, MRCP
(Institute of Psychiatry)
|
The institution of Dr. Richardson has received research support from Medical Research Council UK. The institution of Dr. Richardson has received research support from Epilepsy Research UK. The institution of Dr. Richardson has received research support from GW Pharma. The institution of Dr. Richardson has received research support from European Commission. The institution of Dr. Richardson has received research support from Autifony Therapeutics . The institution of Dr. Richardson has received research support from Epilepsy Foundation of America . Dr. Richardson has received intellectual property interests from a discovery or technology relating to health care. |
|
Matthias J. Koepp, MD, PhD
|
Dr. Koepp has stock in PrevEp. The institution of Dr. Koepp has received research support from Wellcome Trust. |